Aptose Biosciences, Inc. - Common Shares (APTO) earnings
Quarterly and annual APTO reports and results, each read against the price at its own news timestamp. Back to the APTO overview →
11 measured APTO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aptose Reports First Quarter 2026 Results | Press release | — | — | |
| Aptose Reports Second Quarter 2025 Results | Press release | — | — | |
| Form 10-Q Aptose Biosciences Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Aptose Reports First Quarter 2025 Results | Press release | — | — | |
| Form 10-Q Aptose Biosciences Inc. For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Aptose Reports Results for the Third Quarter 2024 | Press release | — | — | |
| Aptose Reports Results for the Second Quarter 2024 | Press release | +0.00% | -7.79% | |
| Aptose Reports Results for the First Quarter 2024 | Press release | +0.00% | -2.98% | |
| Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024 | Press release | +0.59% | +1.19% | |
| Aptose Reports Results for the Third Quarter 2023 | Press release | +0.00% | -15.00% | |
| Aptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023 | Press release | +0.00% | +11.46% |
Keep exploring
More APTO: analyst actions → · SEC filings → · APTO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NOVONESIS B UNSP/ADR (NVZMY) | 155 | +0.05% | 57% |
| PROMETIC LIFE SCIENCE (PFSCF) | 153 | 0.00% | 34% |
| MEI Pharma, Inc. (MEIP) | 152 | +0.07% | 51% |
| Milestone Scientific, Inc. (MLSS) | 152 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.